BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parra A, Clares B, Rosselló A, Garduño-Ramírez ML, Abrego G, García ML, Calpena AC. Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent. Int J Pharm 2016;501:10-7. [PMID: 26826569 DOI: 10.1016/j.ijpharm.2016.01.056] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bustos-Salgado P, Andrade-Carrera B, Domínguez-Villegas V, Rodríguez-Lagunas MJ, Boix-Montañes A, Calpena-Campmany A, Garduño-Ramírez ML. Biopharmaceutic study and in vivo efficacy of natural and derivatives flavanones formulations. Nanomedicine (Lond) 2021;16:205-20. [PMID: 33480290 DOI: 10.2217/nnm-2020-0368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rincón M, Calpena AC, Clares B, Espina M, Garduño-ramírez ML, Rodríguez-lagunas MJ, García ML, Abrego G. Skin-controlled release lipid nanosystems of pranoprofen for the treatment of local inflammation and pain. Nanomedicine 2018;13:2397-413. [DOI: 10.2217/nnm-2018-0195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Gómez-Segura L, Parra A, Calpena-Campmany AC, Gimeno Á, Gómez de Aranda I, Boix-Montañes A. Ex Vivo Permeation of Carprofen Vehiculated by PLGA Nanoparticles through Porcine Mucous Membranes and Ophthalmic Tissues. Nanomaterials (Basel) 2020;10:E355. [PMID: 32085577 DOI: 10.3390/nano10020355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Balestrin LA, Fachel FNS, Koester LS, Bassani VL, Teixeira HF. A stability-indicating ultra-fast liquid chromatography method for the assay of the main flavonoids of Achyrocline satureioides (Marcela) in porcine skin layers and nanoemulsions. Phytochem Anal 2020;31:905-14. [PMID: 32573881 DOI: 10.1002/pca.2962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Güngör S, Kahraman E. Nanocarriers Mediated Cutaneous Drug Delivery. European Journal of Pharmaceutical Sciences 2021;158:105638. [DOI: 10.1016/j.ejps.2020.105638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Üner B, Özdemir S, Taş Ç, Özsoy Y, Üner M. Development of Lipid Nanoparticles for Transdermal Loteprednol Etabonate Delivery. J Microencapsul 2022;:1-27. [PMID: 35583383 DOI: 10.1080/02652048.2022.2079744] [Reference Citation Analysis]
7 Mogharbel BF, Cardoso MA, Irioda AC, Stricker PEF, Slompo RC, Appel JM, de Oliveira NB, Perussolo MC, Saçaki CS, da Rosa NN, Dziedzic DSM, Travelet C, Halila S, Borsali R, de Carvalho KAT. Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease. Molecules 2022;27:2811. [PMID: 35566173 DOI: 10.3390/molecules27092811] [Reference Citation Analysis]
8 Mallandrich M, Calpena AC, Clares B, Parra A, García ML, Soriano JL, Fernández-Campos F. Nano-engineering of ketorolac tromethamine platforms for ocular treatment of inflammatory disorders. Nanomedicine (Lond) 2021;16:401-14. [PMID: 33586454 DOI: 10.2217/nnm-2020-0403] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bali NR, Shinde MP, Rathod SB, Salve PS. Enhanced transdermal permeation of rasagiline mesylate nanoparticles: design, optimization, and effect of binary combinations of solvent systems across biological membrane. International Journal of Polymeric Materials and Polymeric Biomaterials 2021;70:158-73. [DOI: 10.1080/00914037.2019.1706507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Panonnummal R, Jayakumar R, Sabitha M. Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream. European Journal of Pharmaceutical Sciences 2017;96:193-206. [DOI: 10.1016/j.ejps.2016.09.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
11 Gonzalez-pizarro R, Silva-abreu M, Calpena AC, Egea MA, Espina M, García ML. Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye. International Journal of Pharmaceutics 2018;547:338-46. [DOI: 10.1016/j.ijpharm.2018.05.050] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
12 Soriano-Ruiz JL, Suñer-Carbó J, Calpena-Campmany AC, Bozal-de Febrer N, Halbaut-Bellowa L, Boix-Montañés A, Souto EB, Clares-Naveros B. Clotrimazole multiple W/O/W emulsion as anticandidal agent: Characterization and evaluation on skin and mucosae. Colloids Surf B Biointerfaces 2019;175:166-74. [PMID: 30530002 DOI: 10.1016/j.colsurfb.2018.11.070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
13 Dragicevic N, Maibach H. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement. Adv Drug Deliv Rev 2018;127:58-84. [PMID: 29425769 DOI: 10.1016/j.addr.2018.02.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
14 Mota AH, Rijo P, Molpeceres J, Reis CP. Broad overview of engineering of functional nanosystems for skin delivery. International Journal of Pharmaceutics 2017;532:710-28. [DOI: 10.1016/j.ijpharm.2017.07.078] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
15 Ternullo S, de Weerd L, Flaten GE, Holsæter AM, Škalko-Basnet N. The isolated perfused human skin flap model: A missing link in skin penetration studies? Eur J Pharm Sci 2017;96:334-41. [PMID: 27720898 DOI: 10.1016/j.ejps.2016.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
16 Theochari I, Ilic T, Nicolic I, Dobricic V, Tenchiou A, Papahatjis D, Savic S, Xenakis A, Papadimitriou V, Pletsa V. Biological Evaluation of Oil-in-Water Microemulsions as Carriers of Benzothiophene Analogues for Dermal Applications. Biomimetics (Basel) 2021;6:10. [PMID: 33514031 DOI: 10.3390/biomimetics6010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Miranda GM, Santos VORE, Bessa JR, Teles YCF, Yahouédéhou SCMA, Goncalves MS, Ribeiro-Filho J. Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review. Biomolecules 2021;11:361. [PMID: 33673414 DOI: 10.3390/biom11030361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Silva-abreu M, Gonzalez-pizarro R, Espinoza LC, Rodríguez-lagunas MJ, Espina M, García ML, Calpena AC. Thiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease. European Journal of Pharmaceutical Sciences 2019;129:173-80. [DOI: 10.1016/j.ejps.2019.01.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Debotton N, Badihi A, Robinpour M, Enk CD, Benita S. Dermal absorption behavior of fluorescent molecules in nanoparticles on human and porcine skin models. International Journal of Pharmaceutics 2017;524:290-303. [DOI: 10.1016/j.ijpharm.2017.03.091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Baccarin T, Lemos-Senna E. Potential Application of Nanoemulsions for Skin Delivery of Pomegranate Peel Polyphenols. AAPS PharmSciTech 2017;18:3307-14. [PMID: 28597364 DOI: 10.1208/s12249-017-0818-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
21 Roque LV, Dias IS, Cruz N, Rebelo A, Roberto A, Rijo P, Reis CP. Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia. Skin Pharmacol Physiol 2017;30:197-204. [DOI: 10.1159/000475473] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]
22 Soriano-Ruiz JL, Calpena-Capmany AC, Cañadas-Enrich C, Febrer NB, Suñer-Carbó J, Souto EB, Clares-Naveros B. Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent. Int J Pharm 2019;554:105-15. [PMID: 30395953 DOI: 10.1016/j.ijpharm.2018.11.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
23 Silva-Abreu M, Espinoza LC, Rodríguez-Lagunas MJ, Fábrega MJ, Espina M, García ML, Calpena AC. Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes. Int J Mol Sci 2017;18:E2548. [PMID: 29182532 DOI: 10.3390/ijms18122548] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
24 Rincón M, Calpena AC, Fabrega MJ, Garduño-Ramírez ML, Espina M, Rodríguez-Lagunas MJ, García ML, Abrego G. Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders. Nanomaterials (Basel) 2018;8:E1022. [PMID: 30544628 DOI: 10.3390/nano8121022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]